Article
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
Antimicrobial agents and chemotherapy - 1 Oct 1993
Blazquez J, Baquero M R, Canton R, Alos I, Baquero F
Abstract excerpt
A clinical Escherichia coli strain highly resistant to the combinations of amoxicillin-clavulanate, ampicillin-sulbactam, and piperacillin-tazobactam was isolated from a patient with a community-acquired urinary tract infection who was previously treated with amoxicillin-clavulanate. These resist...
Topics
- Clavulanic Acid
- Clavulanic Acids
- Cloning, Molecular
- Drug Resistance, Microbial
- Escherichia coli
- Genes, Bacterial
- Humans
- Mutation
- Penicillanic Acid
- Phenotype
- Sulbactam
- Tazobactam
- beta-Lactamase Inhibitors
- beta-Lactamases
